Relavo

?? Meet the Founder Transforming Home Dialysis ?? Home dialysis is the future of kidney care—but infection risk remains the biggest barrier. Sarah Lee's passion is personal, her vision is bold, and her mission is clear: make peritoneal dialysis (PD) safer and more accessible. Now is the time to invest in the future of home dialysis. #MeetTheFounder #HealthcareInnovation #Dialysis #InvestInTheFuture #MedicalTech

We at the National Kidney Foundation are proud to be an early investor in Relavo through the NKF Innovation Fund. We only invest in innovators that will deliver significant patient benefits and Relavo is a perfect example of this. #NKFInnovationFund

For patients with chronic kidney disease, home dialysis offers freedom, flexibility, and better quality of life. Until major breakthroughs in kidney transplantation arrive, home dialysis is the best path forward. Yet, barriers remain—and the biggest one? Infection risk. This is a solvable problem, and Relavo Medical is solving it. At the heart of this mission is Sarah Lee, our founder and CEO, whose passion for improving peritoneal dialysis (PD) is personal and relentless. In this interview, she shares why she’s dedicated to making home dialysis safer, more accessible, and the standard of care. ?? Read the full interview: https://lnkd.in/eEYXps2R If you believe in disrupting kidney care for the better, now is the time to invest. Let’s change lives—together. #HealthcareInnovation #Dialysis #InvestInTheFuture #MedicalTechnology #ChronicKidneyDisease #PD #HomeDialysis

The?FDA just approved #clinicaltrials?for genetically modified?pig kidneys?in human patients—a major step in?xenotransplantation. The need is urgent: ???100,000+?patients are on the #kidney transplant waitlist ???Less than 25,000?transplants were done in 2023 ???130,000+ new cases?of kidney failure each year With the severe transplant shortage,?dialysis care remains a critical lifeline?for thousands of patients. While safety & efficacy remain key questions, this trial could be a game-changer. Other solutions to watch:?living donors, reducing organ waste, and improving viability. Read more:?https://lnkd.in/ehk6USNv #Biotech #KidneyTransplant #dialysis

?? Watch as board member Pete Schommer shares his thoughts on Relavo’s leadership and vision for transforming home dialysis. His insights highlight the passion and innovation driving our mission to make peritoneal dialysis safer and more accessible. Read the full interview at https://lnkd.in/euNfBuWc #Relavo #Leadership #DialysisInnovation #MedTech #Healthcare

???Exciting News!??? We are thrilled to share that our CEO, Sarah Lee, won the Ignite Fire Pitch competition, and received awards from Johnson & Johnson and Wilson Sonsini Goodrich & Rosati! Competing alongside an incredible group of innovators was an inspiring experience (shoutout to Therese Canares, MD, MBA, Andrea Ippolito, Ashley Yesayan, Kadambari Beelwar, Mimi Gendreau Kigawa, Christine Rohan for being amazing founders!!) We’re honored to have our vision to improve home kidney care be recognized. A huge thank you to the organizers, judges, sponsors, and everyone who supported us along the way, and a special shoutout to the Ignite team, Ayse McCracken, Cheryl Stavins, Mackenzie Lee, MBA, for putting on such an incredible event!

We are delighted to welcome Allen Sun and Yolander A. to Relavo as Product Development Engineering Interns for the Fall 2024 semester! Allen is a senior studying Mechanical Engineering at NYU Tandon School of Engineering. Yolander is a 2nd year Masters student studying Biomedical Engineering also at NYU Tandon School of Engineering. Both interns are getting hands-on experience with medical device development and have already contributed greatly to the team! Thank you to the LifeSci NYC Internship Program for their support.

Last week was a busy week! Our CEO Sarah Lee pitched at the Philadelphia Alliance for Capital and Technologies (PACT) Mid-Atlantic Capital Conference. Sarah Lee and Tejasvi Desai also presented at the Keiretsu Forum Mid-Atlantic Investor Capital Expo. We are excited to spread awareness of our work solving a big problem in kidney disease.

We are delighted to welcome?Pete Schommer?to Relavo's Board of Directors! Pete brings over 25 years of experience in the medical device industry, having led teams at leading companies like?Kendall Healthcare,?Covidien (Medtronic Minimally Invasive Therapies Group), and?Medtronic. ? As the Founder and CEO of Surgenti Consulting LLC, Pete has a proven track record of driving innovation, executing complex integrations, and revitalizing product lines. His deep expertise in operations, M&A, and strategic growth will be a tremendous asset as we continue to advance our mission at Relavo. Please join us in welcoming Pete to the team! ? #Leadership #Innovation #MedTech #Growth

We are delighted to welcome?Pete Schommer?to Relavo's Board of Directors! Pete brings over 25 years of experience in the medical device industry, having led teams at leading companies like?Kendall Healthcare,?Covidien (Medtronic Minimally Invasive Therapies Group), and?Medtronic. ? As the Founder and CEO of Surgenti Consulting LLC, Pete has a proven track record of driving innovation, executing complex integrations, and revitalizing product lines. His deep expertise in operations, M&A, and strategic growth will be a tremendous asset as we continue to advance our mission at Relavo. Please join us in welcoming Pete to the team! ? #Leadership #Innovation #MedTech #Growth